Fuan Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN

P/E

19.64

P/S

2.30

EPS

0.24

Div Yield, %

1.08%

Shrs. gr., 5y

-0.40%

Rev. gr., 5y

-2.97%

Revenues

2.39b

-9.68%

Net income

280m

+20.69%

CFO

304m

-7.72%

Dividend

Jun 04, 20240.05 CNY/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells pharmaceutical intermediates, bulk drugs, and formulations in the People's Republic of China. It offers APIs and intermediates, as well as formulations, such as anti-infective, cardiovascular, digestive, leaflet, and other products. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) Co., Ltd. and changed its name to Fuan Pharmaceutical (Group) Co., Ltd. in August 2013. Fuan Pharmaceutical (Group) Co., Ltd. was founded in 2004 and is headquartered in Chongqing, the People's Republic of China.

URL

https://www.fapharm.com/

IPO date

Mar 22, 2011

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2024‑12	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT